Glycolysis inhibition and its effect in doxorubicin resistance in neuroblastoma

Journal of Pediatric Surgery

Volumn 49, Issue 6, 2014, Pages 981-984

  Bean, Jonathan F ^a   Qiu, Yi Yong ^a   Yu, Songtao ^a   Clark, Sandra ^a   Chu, Fei ^a   Madonna, Mary Beth ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

3 bromopyruvate; ATP; Doxorubicin; Glycolysis inhibition; Neuroblastoma

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; BROMOPYRUVIC ACID; DOXORUBICIN; LACTIC ACID; PYRUVIC ACID DERIVATIVE; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC;

ARTICLE; CANCER CELL LINE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GLYCOLYSIS; HUMAN; HUMAN CELL; HYPOXIA; IC 50; INCUBATION TIME; LUMINESCENCE; MTT ASSAY; NEUROBLASTOMA; PRIORITY JOURNAL; CELL SURVIVAL; DRUG EFFECTS; DRUG RESISTANCE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GLYCOLYSIS; HUMANS; NEUROBLASTOMA;

EID: 84901816878     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2014.01.037     Document Type: Article

References (16)

1. O. Warburg On the origin of cancer cells Science 123 1956 309 314
2. E. Bustamante, and P. Pederson High aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinase Proc Natl Acad Sci U S A 74 1977 3735 3739
3. A. Wolf, S. Agnihotri, and J. Micallef et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme J Exp Med 208 2011 313 326
4. V. Bhardway, N. Rizvi, and M.B. Lai et al. Glycolytic enzyme inhibitors affect pancreatic cancer survival by modulating its signaling and energetics Anticancer Res 30 2010 743 749
5. J. Geschwind, Y. Ko, and M. Torbenson et al. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production Cancer Res 62 2002 3909 3913
6. A.G. Levy, P.E. Zage, and L.J. Akers et al. The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma Invest New Drugs 30 2012 191 199
7. X.H. Liu, X.F. Zheng, and Y.L. Wang Inhibitive effect of 3-bromopyruvic avid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction Chin Med J 122 2009 1681 1685
8. C. Munoz-Pineda, C. Ruiz-Ruiz, and C. de Almodovar et al. Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signaling complex formation and apical Procaspase-8 processing J Biol Chem 278 2003 12759 12768
9. A.P. Pereira da Silva, T. El-bacha, and N. Kyaw et al. Inhibition of energy producing pathways of HepG2 cells by 3-bromopyruvate Biochem J 417 2009 717 726
10. R.H. Xu, H. Pelicano, and Y. Zhou et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia Cancer Res 65 2005 613 621
11. R.H. Xu, H. Pelicano, and H. Zhang et al. Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells Leukemia 19 2005 2153 2158
12. L. Strandburg Ihrlund, E. Hernlund, and O. Khan et al. 3-bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs Mol Oncol 2 2008 94 101
13. J. Endicott, and V. Ling The biochemistry of P-glycoprotein mediated multidrug resistance Annu Rev Biochem 58 1989 137 171
14. A. Shapiro, and V. Ling ATPase Activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells J Biol Chem 269 5 1994 3745 3754
15. J.F. Geschwind, C.S. Georgiades, and Y.H. Ko et al. Recently elucidated energy catabolism pathways provide opportunities for novel treatment in hepatocellular carcinoma Expert Rev Anticancer Ther 4 2004 449 457
16. Y.H. Ko, P. Pedersen, and J.F. Geschwind Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting of hexokinase Cancer Lett 173 2001 83 91